Intravenous methotrexate at a dose of 1 g/m2 incorporated into RCHOP prevented CNS relapse in high-risk DLBCL patients: A prospective, historic controlled study.
Wei WangYan ZhangLu ZhangChen YangJun FengHuacong CaiMiao ChenXinxin CaoJunling ZhuangTienan ZhuMinghui DuanWei ZhangJian LiDaobin ZhouPublished in: American journal of hematology (2020)